Edition:
United Kingdom

Alembic Pharmaceuticals Ltd (ALEM.NS)

ALEM.NS on National Stock Exchange of India

536.90INR
25 Mar 2019
Change (% chg)

Rs-3.35 (-0.62%)
Prev Close
Rs540.25
Open
Rs540.00
Day's High
Rs543.65
Day's Low
Rs534.00
Volume
11,060
Avg. Vol
43,796
52-wk High
Rs664.00
52-wk Low
Rs414.40

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Dec 10,181.50 9.010
Sep 11,270.60 10.610
Jun 8,625.30 4.800
FY 2018 Mar '18 8,533.20 4.978
Dec 8,400.20 6.930
Sep 7,892.90 6.450
Jun 6,481.90 3.540
FY 2017 Mar '17 7,413.50 4.935
Dec 7,770.30 4.591
Sep 8,794.20 6.356
Jun 7,413.50 4.940
 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 1 10,115.00 10,115.00 10,115.00 --
Quarter Ending Sep-19 1 10,877.00 10,877.00 10,877.00 --
Year Ending Mar-19 15 39,280.30 40,363.00 35,275.00 35,361.00
Year Ending Mar-20 15 43,079.80 45,421.80 39,512.00 40,418.70
Earnings (per share)
Quarter Ending Jun-19 1 6.57 6.57 6.57 --
Quarter Ending Sep-19 1 7.18 7.18 7.18 --
Year Ending Mar-19 14 29.64 32.50 23.30 25.13
Year Ending Mar-20 14 29.04 34.10 24.70 30.38
Sales and Profit Figures in India Rupee (INR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 25.87 29.30 32.54
P/E High - Last 5 Yrs. 30.29 43.23 48.15
P/E Low - Last 5 Yrs. 11.98 22.71 23.42
Beta 0.37 0.86 0.87
Price to Sales (TTM) 3.11 6.59 8.39
Price to Book (MRQ) -- 5.12 5.27
Price to Tangible Book (MRQ) -- 5.84 6.74
Price to Cash Flow (TTM) 20.95 23.07 24.12
% Owned Institutions -- 0.87 1.65

Dividends

  Company industry sector
Dividend Yield 0.80 1.43 1.35
Dividend Yield - 5 Year Avg 0.82 1.45 1.37
Dividend 5 Year Growth Rate 23.36 3.99 4.70
Payout Ratio(TTM) 20.60 42.18 39.60

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -12.57 5.43 13.45
Sales (TTM) vs TTM 1 Yr. Ago -8.17 6.61 8.02
Sales - 5 Yr. Growth Rate 16.42 10.48 10.85
EPS (MRQ) vs Qtr. 1 Yr. Ago -28.34 45.67 47.68
EPS (TTM) vs TTM 1 Yr. Ago -50.58 -- --
EPS - 5 Yr. Growth Rate 25.38 9.91 10.47
Capital Spending - 5 Yr. Growth Rate 50.33 15.26 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.07 2.18
Current Ratio (MRQ) -- 2.87 2.98
LT Debt to Equity (MRQ) -- 8.87 11.35
Total Debt to Equity (MRQ) -- 12.87 16.02
Interest Coverage (TTM) 144.16 32.47 28.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 71.56 52.10 52.41
Gross Margin - 5 Yr. Avg. 62.28 49.66 50.39
EBITD Margin (TTM) 18.36 -- --
EBITD - 5 Yr. Avg 22.40 17.26 12.43
Operating Margin (TTM) 15.55 13.53 5.77
Operating Margin - 5 Yr. Avg. 20.06 13.69 8.02
Pre-Tax Margin (TTM) 15.46 11.90 4.80
Pre-Tax Margin - 5 Yr. Avg. 19.94 14.11 8.31
Net Profit Margin (TTM) 12.04 8.81 1.53
Net Profit Margin - 5 Yr. Avg. 15.42 10.60 4.72
Effective Tax Rate (TTM) 22.16 22.12 22.13
Effective Tax Rate - 5 Yr. Avg. 22.67 22.26 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) 3,451,547 928,329,132 820,308,580
Net Income/Employee (TTM) 415,467 105,132,015 92,854,694
Receivable Turnover (TTM) -- 5.84 5.82
Inventory Turnover (TTM) -- 2.57 3.41
Asset Turnover (TTM) -- 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 10.98 10.60
Return on Assets - 5 Yr. Avg. 22.27 12.41 11.78
Return on Investment (TTM) -- 14.23 13.82
Return on Investment - 5 Yr. Avg. 34.14 16.18 15.32
Return on Equity (TTM) -- 15.46 15.24
Return on Equity - 5 Yr. Avg. 37.31 17.07 16.41
  1 Year 3 Year 5 Year
Sales % -0.99 18.93 16.42
EPS (TTM) % -44.01 19.63 25.38
Dividend % 0.00 10.06 23.36
Note: Units in Millions of US Dollars

Performance for Alembic Pharmaceuticals Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.62 0.22 99 31
13 Week -2.90 -4.28 99 42
26 Week -19.09 -24.45 74 45
52 Week -25.95 -34.58 66 9
YTD -15.58 -29.34 75 37
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 13.52%
# of Holders: 38
Total Shares Held: 25,479,475
3 Mo. Net Change: -288,372
# New Positions: 2
# Closed Positions: 3
# Increased Positions: 13
# Reduced Positions: 11
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.